JAK2 c.2049A>T ;(p.R683S)

Variant ID: 9-5078362-A-T

NM_004972.3(JAK2):c.2049A>T;(p.R683S)

This variant was identified in 62 publications

View GRCh38 version.




Publications:


Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series.

Annals Of Hematology
Hu, Mengze M; Liu, Rong R; Li, Juanjuan J; Zhang, Lei L; Cao, Jing J; Yue, Mei M; Zhong, Dixiao D; Tang, Ruihong R
Publication Date: 2023-05-20

Variant appearance in text: JAK2: R683S
PubMed Link: 37209119
Variant Present in the following documents:
  • Main text
  • 277_2023_Article_5245.pdf
View BVdb publication page



Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers.

Cancers
Standing, Shaelene S; Tran, Son S; Murguia-Favela, Luis L; Kovalchuk, Olga O; Bose, Pinaki P; Narendran, Aru A
Publication Date: 2022-11-30

Variant appearance in text: JAK2: R683S
PubMed Link: 36497424
Variant Present in the following documents:
  • Main text
  • cancers-14-05942.pdf
View BVdb publication page



RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).

Plos Genetics
Rehn, Jacqueline J; Mayoh, Chelsea C; Heatley, Susan L SL; McClure, Barbara J BJ; Eadie, Laura N LN; Schutz, Caitlin C; Yeung, David T DT; Cowley, Mark J MJ; Breen, James J; White, Deborah L DL
Publication Date: 2022-10

Variant appearance in text: JAK2: R683S
PubMed Link: 36251721
Variant Present in the following documents:
  • Main text
  • pgen.1010300.pdf
View BVdb publication page



JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

Frontiers In Cell And Developmental Biology
Downes, Charlotte Ej CE; McClure, Barbara J BJ; McDougal, Daniel P DP; Heatley, Susan L SL; Bruning, John B JB; Thomas, Daniel D; Yeung, David T DT; White, Deborah L DL
Publication Date: 2022

Variant appearance in text: JAK2: R683S
PubMed Link: 35903543
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics
Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS
Publication Date: 2022-08

Variant appearance in text: JAK2: R683S
PubMed Link: 35835912
Variant Present in the following documents:
  • 41588_2022_1121_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL.

Blood Advances
Aldoss, Ibrahim I; Yang, Dongyun D; Tomasian, Vanina V; Mokhtari, Sally S; Jackson, Ryan R; Gu, Zhaohui Z; Telatar, Milhan M; Yew, Hooi H; Al Malki, Monzr M MM; Salhotra, Amandeep A; Khaled, Samer S; Ali, Haris H; Aribi, Ahmed A; Sandhu, Karamjeet S KS; Mei, Matthew M; Arslan, Shukaib S; Koller, Paul P; Artz, Andrew A; Aoun, Patricia P; Gu, Dongqing D; Snyder, David D; Stewart, Forrest M FM; Curtin, Peter P; Stein, Anthony S AS; Pillai, Raju R; Marcucci, Guido G; Forman, Stephen J SJ; Pullarkat, Vinod V; Nakamura, Ryotaro R; Afkhami, Michelle M
Publication Date: 2022-09-13

Variant appearance in text: JAK2: 2049A>T; R683S
PubMed Link: 35816633
Variant Present in the following documents:
  • advancesADV2022007597-suppl1.xlsx, sheet 1
View BVdb publication page



Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia.

Science Advances
Barsan, Valentin V; Xia, Yuntao Y; Klein, David D; Gonzalez-Pena, Veronica V; Youssef, Sarah S; Inaba, Yuki Y; Mahmud, Ousman O; Natarajan, Sivaraman S; Agarwal, Vibhu V; Pang, Yakun Y; Autry, Robert R; Pui, Ching-Hon CH; Inaba, Hiroto H; Evans, William W; Gawad, Charles C
Publication Date: 2022-04-22

Variant appearance in text: JAK2: R683S
PubMed Link: 35442732
Variant Present in the following documents:
  • sciadv.abj1360.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: JAK2: R683S
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.

Bmc Cancer
Walter, Wencke W; Shahswar, Rabia R; Stengel, Anna A; Meggendorfer, Manja M; Kern, Wolfgang W; Haferlach, Torsten T; Haferlach, Claudia C
Publication Date: 2021-08-02

Variant appearance in text: JAK2: 2049A>T
PubMed Link: 34340673
Variant Present in the following documents:
  • 12885_2021_8635_MOESM9_ESM.xlsx, sheet 1
View BVdb publication page



Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing.

Science Advances
Abelson, Sagi S; Zeng, Andy G X AGX; Nofech-Mozes, Ido I; Wang, Ting Ting TT; Ng, Stanley W K SWK; Minden, Mark D MD; Pugh, Trevor J TJ; Awadalla, Philip P; Shlush, Liran I LI; Murphy, Tracy T; Chan, Steven M SM; Dick, John E JE; Bratman, Scott V SV
Publication Date: 2020-12

Variant appearance in text: JAK2: R683S
PubMed Link: 33298453
Variant Present in the following documents:
  • abe3722_Table_S3.xlsx, sheet 3
View BVdb publication page



Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.

Journal Of Personalized Medicine
Montaño, Adrián A; Hernández-Sánchez, Jesús J; Forero-Castro, Maribel M; Matorra-Miguel, María M; Lumbreras, Eva E; Miguel, Cristina C; Santos, Sandra S; Ramírez-Maldonado, Valentina V; Fuster, José Luís JL; de Las Heras, Natalia N; García-de Coca, Alfonso A; Sierra, Magdalena M; Dávila, Julio J; de la Fuente, Ignacio I; Olivier, Carmen C; Olazabal, Juan J; Martínez, Joaquín J; Vega-García, Nerea N; González, Teresa T; Hernández-Rivas, Jesús María JM; Benito, Rocío R
Publication Date: 2020-09-21

Variant appearance in text: JAK2: 2049A>T; R683S
PubMed Link: 32967112
Variant Present in the following documents:
  • Main text
  • jpm-10-00137.pdf
  • jpm-10-00137-s001.pdf
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: JAK2: R683S
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Genetic Signature of Acute Lymphoblastic Leukemia and Netherton Syndrome Co-incidence-First Report in the Literature.

Frontiers In Oncology
Skoczen, Szymon S; Stepien, Konrad K; Mlynarski, Wojciech W; Centkowski, Piotr P; Kwiecinska, Kinga K; Korostynski, Michal M; Piechota, Marcin M; Wyrobek, Elzbieta E; Moryl-Bujakowska, Angelina A; Strojny, Wojciech W; Rej, Magdalena M; Kowalczyk, Jerzy J; Balwierz, Walentyna W
Publication Date: 2019

Variant appearance in text: JAK2: R683S
PubMed Link: 32010610
Variant Present in the following documents:
  • fonc-09-01477.pdf
View BVdb publication page



Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling.

Cancers
Raivola, Juuli J; Haikarainen, Teemu T; Silvennoinen, Olli O
Publication Date: 2019-12-27

Variant appearance in text: JAK2: R683S
PubMed Link: 31892268
Variant Present in the following documents:
  • Main text
View BVdb publication page



Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer.

Jama Network Open
Vaske, Olena M OM; Bjork, Isabel I; Salama, Sofie R SR; Beale, Holly H; Tayi Shah, Avanthi A; Sanders, Lauren L; Pfeil, Jacob J; Lam, Du L DL; Learned, Katrina K; Durbin, Ann A; Kephart, Ellen T ET; Currie, Rob R; Newton, Yulia Y; Swatloski, Teresa T; McColl, Duncan D; Vivian, John J; Zhu, Jingchun J; Lee, Alex G AG; Leung, Stanley G SG; Spillinger, Aviv A; Liu, Heng-Yi HY; Liang, Winnie S WS; Byron, Sara A SA; Berens, Michael E ME; Resnick, Adam C AC; Lacayo, Norman N; Spunt, Sheri L SL; Rangaswami, Arun A; Huynh, Van V; Torno, Lilibeth L; Plant, Ashley A; Kirov, Ivan I; Zabokrtsky, Keri B KB; Rassekh, S Rod SR; Deyell, Rebecca J RJ; Laskin, Janessa J; Marra, Marco A MA; Sender, Leonard S LS; Mueller, Sabine S; Sweet-Cordero, E Alejandro EA; Goldstein, Theodore C TC; Haussler, David D
Publication Date: 2019-10-02

Variant appearance in text: JAK2: R683S
PubMed Link: 31651965
Variant Present in the following documents:
  • jamanetwopen-2-e1913968-s001.pdf
View BVdb publication page



Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.

Cancer Science
Kubota, Yasuo Y; Uryu, Kumiko K; Ito, Tatsuya T; Seki, Masafumi M; Kawai, Tomoko T; Isobe, Tomoya T; Kumagai, Tadayuki T; Toki, Tsutomu T; Yoshida, Kenichi K; Suzuki, Hiromichi H; Kataoka, Keisuke K; Shiraishi, Yuichi Y; Chiba, Kenichi K; Tanaka, Hiroko H; Ohki, Kentaro K; Kiyokawa, Nobutaka N; Kagawa, Jiro J; Miyano, Satoru S; Oka, Akira A; Hayashi, Yasuhide Y; Ogawa, Seishi S; Terui, Kiminori K; Sato, Atsushi A; Hata, Kenichiro K; Ito, Etsuro E; Takita, Junko J
Publication Date: 2019-10

Variant appearance in text: JAK2: R683S
PubMed Link: 31385395
Variant Present in the following documents:
  • CAS-110-3358-s023.xlsx, sheet 1
  • CAS-110-3358-s024.xlsx, sheet 1
View BVdb publication page



Clinical utility of custom-designed NGS panel testing in pediatric tumors.

Genome Medicine
Surrey, Lea F LF; MacFarland, Suzanne P SP; Chang, Fengqi F; Cao, Kajia K; Rathi, Komal S KS; Akgumus, Gozde T GT; Gallo, Daniel D; Lin, Fumin F; Gleason, Adam A; Raman, Pichai P; Aplenc, Richard R; Bagatell, Rochelle R; Minturn, Jane J; Mosse, Yael Y; Santi, Mariarita M; Tasian, Sarah K SK; Waanders, Angela J AJ; Sarmady, Mahdi M; Maris, John M JM; Hunger, Stephen P SP; Li, Marilyn M MM
Publication Date: 2019-05-28

Variant appearance in text: JAK2: 2049A>T; Arg683Ser
PubMed Link: 31133068
Variant Present in the following documents:
  • 13073_2019_644_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations.

The Journal Of Allergy And Clinical Immunology
Hammarén, Henrik M HM; Virtanen, Anniina T AT; Abraham, Bobin George BG; Peussa, Heidi H; Hubbard, Stevan R SR; Silvennoinen, Olli O
Publication Date: 2019-04

Variant appearance in text: JAK2: R683S
PubMed Link: 30092288
Variant Present in the following documents:
  • Main text
View BVdb publication page



Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.

Oncotarget
Tarlock, Katherine K; Zhong, Shan S; He, Yuting Y; Ries, Rhonda R; Severson, Eric E; Bailey, Mark M; Morley, Samantha S; Balasubramanian, Sohail S; Erlich, Rachel R; Lipson, Doron D; Otto, Geoff A GA; Vergillo, Jo-Anne JA; Kolb, E Anders EA; Ross, Jeffrey S JS; Mughal, Tariq T; Stephens, Philip J PJ; Miller, Vincent V; Meshinchi, Soheil S; He, Jie J
Publication Date: 2018-05-29

Variant appearance in text: JAK2: 2049A>T; R683S
PubMed Link: 29899868
Variant Present in the following documents:
  • oncotarget-09-26417-s005.xlsx, sheet 1
View BVdb publication page



Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent Cancer.

Frontiers In Pediatrics
Østrup, Olga O; Nysom, Karsten K; Scheie, David D; Schmidt, Ane Y AY; Mathiasen, Rene R; Hjalgrim, Lisa L LL; Olsen, Tina E TE; Skjøth-Rasmussen, Jane J; Henriksen, Birthe M BM; Nielsen, Finn C FC; Wehner, Peder S PS; Schrøder, Henrik H; Sehested, Astrid M AM; Rechnitzer, Catherine C; Rossing, Maria M
Publication Date: 2018

Variant appearance in text: JAK2: R683S
PubMed Link: 29732366
Variant Present in the following documents:
  • Main text
  • fped-06-00114.pdf
View BVdb publication page



New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.

Cancers
Montaño, Adrián A; Forero-Castro, Maribel M; Marchena-Mendoza, Darnel D; Benito, Rocío R; Hernández-Rivas, Jesús María JM
Publication Date: 2018-04-07

Variant appearance in text: JAK2: R683S
PubMed Link: 29642462
Variant Present in the following documents:
  • cancers-10-00110.pdf
View BVdb publication page



[Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia].

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
Feng, J J; Gong, X Y XY; Jia, Y J YJ; Liu, K Q KQ; Li, Y Y; Dong, X B XB; Fang, Q Y QY; Ru, K K; Li, Q H QH; Wang, H J HJ; Zhao, X L XL; Jia, Y N YN; Song, Y Y; Tian, Z Z; Wang, M M; Tang, K J KJ; Wang, J X JX; Mi, Y C YC
Publication Date: 2018-02-14

Variant appearance in text: JAK2: R683S
PubMed Link: 29562441
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

Nature
Ma, Xiaotu X; Liu, Yu Y; Liu, Yanling Y; Alexandrov, Ludmil B LB; Edmonson, Michael N MN; Gawad, Charles C; Zhou, Xin X; Li, Yongjin Y; Rusch, Michael C MC; Easton, John J; Huether, Robert R; Gonzalez-Pena, Veronica V; Wilkinson, Mark R MR; Hermida, Leandro C LC; Davis, Sean S; Sioson, Edgar E; Pounds, Stanley S; Cao, Xueyuan X; Ries, Rhonda E RE; Wang, Zhaoming Z; Chen, Xiang X; Dong, Li L; Diskin, Sharon J SJ; Smith, Malcolm A MA; Guidry Auvil, Jaime M JM; Meltzer, Paul S PS; Lau, Ching C CC; Perlman, Elizabeth J EJ; Maris, John M JM; Meshinchi, Soheil S; Hunger, Stephen P SP; Gerhard, Daniela S DS; Zhang, Jinghui J
Publication Date: 2018-03-15

Variant appearance in text: JAK2: R683S
PubMed Link: 29489755
Variant Present in the following documents:
  • Main text
  • NIHMS939556-supplement-Table_2-7.xlsx, sheet 6
  • NIHMS939556-supplement-Table_2-7.xlsx, sheet 4
View BVdb publication page



Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.

Oncotarget
Zhang, Qi Q; Shi, Ce C; Han, Lina L; Jain, Nitin N; Roberts, Kathryn G KG; Ma, Helen H; Cai, Tianyu T; Cavazos, Antonio A; Tabe, Yoko Y; Jacamo, Rodrigo O RO; Mu, Hong H; Zhao, Yang Y; Wang, Jing J; Wu, Shuo-Chieh SC; Cao, Fenglin F; Zeng, Zhihong Z; Zhou, Jin J; Mi, Yingchang Y; Jabbour, Elias J EJ; Levine, Ross R; Tasian, Sarah K SK; Mullighan, Charles G CG; Weinstock, David M DM; Fruman, David A DA; Konopleva, Marina M
Publication Date: 2018-01-30

Variant appearance in text: JAK2: R683S
PubMed Link: 29487712
Variant Present in the following documents:
  • Main text
  • oncotarget-09-8027.pdf
  • oncotarget-09-8027-s001.pdf
View BVdb publication page



JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia.

Oncotarget
Steeghs, Elisabeth M P EMP; Jerchel, Isabel S IS; de Goffau-Nobel, Willemieke W; Hoogkamer, Alex Q AQ; Boer, Judith M JM; Boeree, Aurélie A; van de Ven, Cesca C; Koudijs, Marco J MJ; Besselink, Nicolle J M NJM; de Groot-Kruseman, Hester A HA; Zwaan, Christian Michel CM; Horstmann, Martin A MA; Pieters, Rob R; den Boer, Monique L ML
Publication Date: 2017-10-27

Variant appearance in text: JAK2: R683S
PubMed Link: 29163799
Variant Present in the following documents:
  • Main text
  • oncotarget-08-89923.pdf
View BVdb publication page



Prevalence and detection of low-allele-fraction variants in clinical cancer samples.

Nature Communications
Shin, Hyun-Tae HT; Choi, Yoon-La YL; Yun, Jae Won JW; Kim, Nayoung K D NKD; Kim, Sook-Young SY; Jeon, Hyo Jeong HJ; Nam, Jae-Yong JY; Lee, Chung C; Ryu, Daeun D; Kim, Sang Cheol SC; Park, Kyunghee K; Lee, Eunjin E; Bae, Joon Seol JS; Son, Dae Soon DS; Joung, Je-Gun JG; Lee, Jeeyun J; Kim, Seung Tae ST; Ahn, Myung-Ju MJ; Lee, Se-Hoon SH; Ahn, Jin Seok JS; Lee, Woo Yong WY; Oh, Bo Young BY; Park, Yeon Hee YH; Lee, Jeong Eon JE; Lee, Kwang Hyuk KH; Kim, Hee Cheol HC; Kim, Kyoung-Mee KM; Im, Young-Hyuck YH; Park, Keunchil K; Park, Peter J PJ; Park, Woong-Yang WY
Publication Date: 2017-11-09

Variant appearance in text: JAK2: R683S
PubMed Link: 29123093
Variant Present in the following documents:
  • 41467_2017_1470_MOESM11_ESM.xlsx, sheet 1
View BVdb publication page



Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Blood
Nieborowska-Skorska, Margaret M; Maifrede, Silvia S; Dasgupta, Yashodhara Y; Sullivan, Katherine K; Flis, Sylwia S; Le, Bac Viet BV; Solecka, Martyna M; Belyaeva, Elizaveta A EA; Kubovcakova, Lucia L; Nawrocki, Morgan M; Kirschner, Martin M; Zhao, Huaqing H; Prchal, Josef T JT; Piwocka, Katarzyna K; Moliterno, Alison R AR; Wasik, Mariusz M; Koschmieder, Steffen S; Green, Tony R TR; Skoda, Radek C RC; Skorski, Tomasz T
Publication Date: 2017-12-28

Variant appearance in text: JAK2: R683S
PubMed Link: 29042365
Variant Present in the following documents:
  • Main text
View BVdb publication page



Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.

Haematologica
Jain, Nitin N; Lu, Xinyan X; Daver, Naval N; Thakral, Beenu B; Wang, Sa A SA; Konoplev, Sergej S; Patel, Keyur K; Kanagal-Shamanna, Rashmi R; Valentine, Marcus M; Tang, Guilin G; Pemmaraju, Naveen N; Jorgensen, Jeffrey J; Kebriaei, Partow P; Nunez, Cesar A CA; Wierda, William W; Jabbour, Elias E; Roberts, Kathryn G KG; Mullighan, Charles G CG; Kantarjian, Hagop H; Konopleva, Marina M
Publication Date: 2017-12

Variant appearance in text: JAK2: R683S
PubMed Link: 28860345
Variant Present in the following documents:
  • Main text
View BVdb publication page



Dysregulation of BCL-2 family proteins by leukemia fusion genes.

The Journal Of Biological Chemistry
Brown, Lauren M LM; Hanna, Diane T DT; Khaw, Seong L SL; Ekert, Paul G PG
Publication Date: 2017-09-01

Variant appearance in text: JAK2: R683S
PubMed Link: 28717011
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.

British Journal Of Cancer
Forero-Castro, Maribel M; Robledo, Cristina C; Benito, Rocío R; Bodega-Mayor, Irene I; Rapado, Inmaculada I; Hernández-Sánchez, María M; Abáigar, María M; Maria Hernández-Sánchez, Jesús J; Quijada-Álamo, Miguel M; María Sánchez-Pina, José J; Sala-Valdés, Mónica M; Araujo-Silva, Fernanda F; Kohlmann, Alexander A; Luis Fuster, José J; Arefi, Maryam M; de Las Heras, Natalia N; Riesco, Susana S; Rodríguez, Juan N JN; Hermosín, Lourdes L; Ribera, Jordi J; Camos Guijosa, Mireia M; Ramírez, Manuel M; de Heredia Rubio, Cristina Díaz CD; Barragán, Eva E; Martínez, Joaquín J; Ribera, José M JM; Fernández-Ruiz, Elena E; Hernández-Rivas, Jesús-María JM
Publication Date: 2017-07-11

Variant appearance in text: JAK2: R683S
PubMed Link: 28557976
Variant Present in the following documents:
  • Main text
  • bjc2017152a.pdf
View BVdb publication page



The promise of Janus kinase inhibitors in the treatment of hematological malignancies.

Cytokine
Senkevitch, Emilee E; Durum, Scott S
Publication Date: 2017-10

Variant appearance in text: JAK2: R683S
PubMed Link: 28277287
Variant Present in the following documents:
  • Main text
View BVdb publication page



Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.

Blood
Jain, Nitin N; Roberts, Kathryn G KG; Jabbour, Elias E; Patel, Keyur K; Eterovic, Agda Karina AK; Chen, Ken K; Zweidler-McKay, Patrick P; Lu, Xinyan X; Fawcett, Gloria G; Wang, Sa A SA; Konoplev, Sergej S; Harvey, Richard C RC; Chen, I-Ming IM; Payne-Turner, Debbie D; Valentine, Marcus M; Thomas, Deborah D; Garcia-Manero, Guillermo G; Ravandi, Farhad F; Cortes, Jorge J; Kornblau, Steven S; O'Brien, Susan S; Pierce, Sherry S; Jorgensen, Jeffrey J; Shaw, Kenna R Mills KR; Willman, Cheryl L CL; Mullighan, Charles G CG; Kantarjian, Hagop H; Konopleva, Marina M
Publication Date: 2017-02-02

Variant appearance in text: JAK2: R683S
PubMed Link: 27919910
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.

Leukemia
Vesely, C C; Frech, C C; Eckert, C C; Cario, G G; Mecklenbräuker, A A; Zur Stadt, U U; Nebral, K K; Kraler, F F; Fischer, S S; Attarbaschi, A A; Schuster, M M; Bock, C C; Cavé, H H; von Stackelberg, A A; Schrappe, M M; Horstmann, M A MA; Mann, G G; Haas, O A OA; Panzer-Grümayer, R R
Publication Date: 2017-07

Variant appearance in text: JAK2: R683S
PubMed Link: 27899802
Variant Present in the following documents:
  • leu2016365x3.xlsx, sheet 1
View BVdb publication page



Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

Cancer Research
Ding, Ling-Wen LW; Sun, Qiao-Yang QY; Tan, Kar-Tong KT; Chien, Wenwen W; Mayakonda, Anand A; Yeoh, Allen Eng Juh AEJ; Kawamata, Norihiko N; Nagata, Yasunobu Y; Xiao, Jin-Fen JF; Loh, Xin-Yi XY; Lin, De-Chen DC; Garg, Manoj M; Jiang, Yan-Yi YY; Xu, Liang L; Lim, Su-Lin SL; Liu, Li-Zhen LZ; Madan, Vikas V; Sanada, Masashi M; Fernández, Lucia Torres LT; Hema Preethi, S S SS; Lill, Michael M; Kantarjian, Hagop M HM; Kornblau, Steven M SM; Miyano, Satoru S; Liang, Der-Cherng DC; Ogawa, Seishi S; Shih, Lee-Yung LY; Yang, Henry H; Koeffler, H Phillip HP
Publication Date: 2017-01-15

Variant appearance in text: JAK2: R683S
PubMed Link: 27872090
Variant Present in the following documents:
  • Main text
View BVdb publication page



The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.

Leukemia
Lee, P P; Bhansali, R R; Izraeli, S S; Hijiya, N N; Crispino, J D JD
Publication Date: 2016-09

Variant appearance in text: JAK2: R683S
PubMed Link: 27285583
Variant Present in the following documents:
  • Main text
View BVdb publication page



Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.

Blood Cancer Journal
Imamura, T T; Kiyokawa, N N; Kato, M M; Imai, C C; Okamoto, Y Y; Yano, M M; Ohki, K K; Yamashita, Y Y; Kodama, Y Y; Saito, A A; Mori, M M; Ishimaru, S S; Deguchi, T T; Hashii, Y Y; Shimomura, Y Y; Hori, T T; Kato, K K; Goto, H H; Ogawa, C C; Koh, K K; Taki, T T; Manabe, A A; Sato, A A; Kikuta, A A; Adachi, S S; Horibe, K K; Ohara, A A; Watanabe, A A; Kawano, Y Y; Ishii, E E; Shimada, H H
Publication Date: 2016-05-13

Variant appearance in text: JAK2: R683S
PubMed Link: 27176795
Variant Present in the following documents:
  • Main text
  • bcj201628a.pdf
View BVdb publication page



Uncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix.

The Biochemical Journal
Leroy, Emilie E; Dusa, Alexandra A; Colau, Didier D; Motamedi, Amir A; Cahu, Xavier X; Mouton, Céline C; Huang, Lily J LJ; Shiau, Andrew K AK; Constantinescu, Stefan N SN
Publication Date: 2016-06-01

Variant appearance in text: JAK2: R683S
PubMed Link: 27029346
Variant Present in the following documents:
  • Main text
View BVdb publication page



Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.

Oncotarget
Messina, Monica M; Chiaretti, Sabina S; Wang, Jiguang J; Fedullo, Anna Lucia AL; Peragine, Nadia N; Gianfelici, Valentina V; Piciocchi, Alfonso A; Brugnoletti, Fulvia F; Di Giacomo, Filomena F; Pauselli, Simona S; Holmes, Antony B AB; Puzzolo, Maria Cristina MC; Ceglie, Giulia G; Apicella, Valerio V; Mancini, Marco M; Te Kronnie, Geertruy G; Testi, Anna Maria AM; Vitale, Antonella A; Vignetti, Marco M; Guarini, Anna A; Rabadan, Raul R; Foà, Robin R
Publication Date: 2016-03-22

Variant appearance in text: JAK2: R683S
PubMed Link: 26883104
Variant Present in the following documents:
  • Main text
  • oncotarget-07-13886.pdf
View BVdb publication page



KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.

Leukemia
Malinowska-Ozdowy, K K; Frech, C C; Schönegger, A A; Eckert, C C; Cazzaniga, G G; Stanulla, M M; zur Stadt, U U; Mecklenbräuker, A A; Schuster, M M; Kneidinger, D D; von Stackelberg, A A; Locatelli, F F; Schrappe, M M; Horstmann, M A MA; Attarbaschi, A A; Bock, C C; Mann, G G; Haas, O A OA; Panzer-Grümayer, R R
Publication Date: 2015-08

Variant appearance in text: JAK2: R683S
PubMed Link: 25917266
Variant Present in the following documents:
  • leu2015107x5.xls, sheet 1
View BVdb publication page



ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Hammarén, Henrik M HM; Ungureanu, Daniela D; Grisouard, Jean J; Skoda, Radek C RC; Hubbard, Stevan R SR; Silvennoinen, Olli O
Publication Date: 2015-04-14

Variant appearance in text: JAK2: R683S
PubMed Link: 25825724
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.

Blood
Silvennoinen, Olli O; Hubbard, Stevan R SR
Publication Date: 2015-05-28

Variant appearance in text: JAK2: R683S
PubMed Link: 25824690
Variant Present in the following documents:
  • Main text
View BVdb publication page



Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.

Nature Communications
Ma, Xiaotu X; Edmonson, Michael M; Yergeau, Donald D; Muzny, Donna M DM; Hampton, Oliver A OA; Rusch, Michael M; Song, Guangchun G; Easton, John J; Harvey, Richard C RC; Wheeler, David A DA; Ma, Jing J; Doddapaneni, HarshaVardhan H; Vadodaria, Bhavin B; Wu, Gang G; Nagahawatte, Panduka P; Carroll, William L WL; Chen, I-Ming IM; Gastier-Foster, Julie M JM; Relling, Mary V MV; Smith, Malcolm A MA; Devidas, Meenakshi M; Guidry Auvil, Jaime M JM; Downing, James R JR; Loh, Mignon L ML; Willman, Cheryl L CL; Gerhard, Daniela S DS; Mullighan, Charles G CG; Hunger, Stephen P SP; Zhang, Jinghui J
Publication Date: 2015-03-19

Variant appearance in text: JAK2: R683S
PubMed Link: 25790293
Variant Present in the following documents:
  • Main text
  • ncomms7604-s3.xls, sheet 1
  • ncomms7604.pdf
  • ncomms7604-s6.xls, sheet 1
View BVdb publication page



The molecular regulation of Janus kinase (JAK) activation.

The Biochemical Journal
Babon, Jeffrey J JJ; Lucet, Isabelle S IS; Murphy, James M JM; Nicola, Nicos A NA; Varghese, Leila N LN
Publication Date: 2014-08-15

Variant appearance in text: JAK2: R683S
PubMed Link: 25057888
Variant Present in the following documents:
  • Main text
View BVdb publication page



Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Roberts, Kathryn G KG; Pei, Deqing D; Campana, Dario D; Payne-Turner, Debbie D; Li, Yongjin Y; Cheng, Cheng C; Sandlund, John T JT; Jeha, Sima S; Easton, John J; Becksfort, Jared J; Zhang, Jinghui J; Coustan-Smith, Elaine E; Raimondi, Susana C SC; Leung, Wing H WH; Relling, Mary V MV; Evans, William E WE; Downing, James R JR; Mullighan, Charles G CG; Pui, Ching-Hon CH
Publication Date: 2014-09-20

Variant appearance in text: JAK2: Arg683Ser
PubMed Link: 25049327
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.

Nature Structural & Molecular Biology
Shan, Yibing Y; Gnanasambandan, Kavitha K; Ungureanu, Daniela D; Kim, Eric T ET; Hammarén, Henrik H; Yamashita, Kazuo K; Silvennoinen, Olli O; Shaw, David E DE; Hubbard, Stevan R SR
Publication Date: 2014-07

Variant appearance in text: JAK2: R683S
PubMed Link: 24918548
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.

Nature Communications
Mar, Brenton G BG; Bullinger, Lars B LB; McLean, Kathleen M KM; Grauman, Peter V PV; Harris, Marian H MH; Stevenson, Kristen K; Neuberg, Donna S DS; Sinha, Amit U AU; Sallan, Stephen E SE; Silverman, Lewis B LB; Kung, Andrew L AL; Lo Nigro, Luca L; Ebert, Benjamin L BL; Armstrong, Scott A SA
Publication Date: 2014-03-24

Variant appearance in text: JAK2: R683S
PubMed Link: 24662245
Variant Present in the following documents:
  • NIHMS568254-supplement-1.pdf
View BVdb publication page



Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses.

The Biochemical Journal
Varghese, Leila N LN; Ungureanu, Daniela D; Liau, Nicholas P D NP; Young, Samuel N SN; Laktyushin, Artem A; Hammaren, Henrik H; Lucet, Isabelle S IS; Nicola, Nicos A NA; Silvennoinen, Olli O; Babon, Jeffrey J JJ; Murphy, James M JM
Publication Date: 2014-03-01

Variant appearance in text: JAK2: 2049A>T; R683S
PubMed Link: 24354892
Variant Present in the following documents:
  • Main text
View BVdb publication page



Assessment of computational methods for predicting the effects of missense mutations in human cancers.

Bmc Genomics
Gnad, Florian F; Baucom, Albion A; Mukhyala, Kiran K; Manning, Gerard G; Zhang, Zemin Z
Publication Date: 2013

Variant appearance in text: JAK2: R683S
PubMed Link: 23819521
Variant Present in the following documents:
  • 1471-2164-14-S3-S7-S1.xlsx, sheet 1
View BVdb publication page



Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.

Blood
Loh, Mignon L ML; Zhang, Jinghui J; Harvey, Richard C RC; Roberts, Kathryn K; Payne-Turner, Debbie D; Kang, Huining H; Wu, Gang G; Chen, Xiang X; Becksfort, Jared J; Edmonson, Michael M; Buetow, Kenneth H KH; Carroll, William L WL; Chen, I-Ming IM; Wood, Brent B; Borowitz, Michael J MJ; Devidas, Meenakshi M; Gerhard, Daniela S DS; Bowman, Paul P; Larsen, Eric E; Winick, Naomi N; Raetz, Elizabeth E; Smith, Malcolm M; Downing, James R JR; Willman, Cheryl L CL; Mullighan, Charles G CG; Hunger, Stephen P SP
Publication Date: 2013-01-17

Variant appearance in text: JAK2: Arg683Ser
PubMed Link: 23212523
Variant Present in the following documents:
  • Main text
View BVdb publication page



Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

Blood
van Bodegom, Diederik D; Zhong, Jun J; Kopp, Nadja N; Dutta, Chaitali C; Kim, Min-Sik MS; Bird, Liat L; Weigert, Oliver O; Tyner, Jeffrey J; Pandey, Akhilesh A; Yoda, Akinori A; Weinstock, David M DM
Publication Date: 2012-10-04

Variant appearance in text: JAK2: R683S
PubMed Link: 22915648
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.

The Journal Of Experimental Medicine
Weigert, Oliver O; Lane, Andrew A AA; Bird, Liat L; Kopp, Nadja N; Chapuy, Bjoern B; van Bodegom, Diederik D; Toms, Angela V AV; Marubayashi, Sachie S; Christie, Amanda L AL; McKeown, Michael M; Paranal, Ronald M RM; Bradner, James E JE; Yoda, Akinori A; Gaul, Christoph C; Vangrevelinghe, Eric E; Romanet, Vincent V; Murakami, Masato M; Tiedt, Ralph R; Ebel, Nicolas N; Evrot, Emeline E; De Pover, Alain A; Régnier, Catherine H CH; Erdmann, Dirk D; Hofmann, Francesco F; Eck, Michael J MJ; Sallan, Stephen E SE; Levine, Ross L RL; Kung, Andrew L AL; Baffert, Fabienne F; Radimerski, Thomas T; Weinstock, David M DM
Publication Date: 2012-02-13

Variant appearance in text: JAK2: R683S
PubMed Link: 22271575
Variant Present in the following documents:
  • Main text
  • JEM_20111694.pdf
View BVdb publication page



Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.

Critical Reviews In Oncogenesis
Tasian, Sarah K SK; Loh, Mignon L ML
Publication Date: 2011

Variant appearance in text: JAK2: R683S
PubMed Link: 22150304
Variant Present in the following documents:
  • Main text
View BVdb publication page



The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.

Nature Structural & Molecular Biology
Ungureanu, Daniela D; Wu, Jinhua J; Pekkala, Tuija T; Niranjan, Yashavanthi Y; Young, Clifford C; Jensen, Ole N ON; Xu, Chong-Feng CF; Neubert, Thomas A TA; Skoda, Radek C RC; Hubbard, Stevan R SR; Silvennoinen, Olli O
Publication Date: 2011-08-14

Variant appearance in text: JAK2: R683S
PubMed Link: 21841788
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: JAK2: R683S
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page



Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Blood
Harvey, Richard C RC; Mullighan, Charles G CG; Chen, I-Ming IM; Wharton, Walker W; Mikhail, Fady M FM; Carroll, Andrew J AJ; Kang, Huining H; Liu, Wei W; Dobbin, Kevin K KK; Smith, Malcolm A MA; Carroll, William L WL; Devidas, Meenakshi M; Bowman, W Paul WP; Camitta, Bruce M BM; Reaman, Gregory H GH; Hunger, Stephen P SP; Downing, James R JR; Willman, Cheryl L CL
Publication Date: 2010-07-01

Variant appearance in text: JAK2: R683S
PubMed Link: 20139093
Variant Present in the following documents:
  • Main text
View BVdb publication page



Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Yoda, Akinori A; Yoda, Yuka Y; Chiaretti, Sabina S; Bar-Natan, Michal M; Mani, Kartik K; Rodig, Scott J SJ; West, Nathan N; Xiao, Yun Y; Brown, Jennifer R JR; Mitsiades, Constantine C; Sattler, Martin M; Kutok, Jeffrey L JL; DeAngelo, Daniel J DJ; Wadleigh, Martha M; Piciocchi, Alfonso A; Dal Cin, Paola P; Bradner, James E JE; Griffin, James D JD; Anderson, Kenneth C KC; Stone, Richard M RM; Ritz, Jerome J; Foà, Robin R; Aster, Jon C JC; Frank, David A DA; Weinstock, David M DM
Publication Date: 2010-01-05

Variant appearance in text: JAK2: Arg683Ser
PubMed Link: 20018760
Variant Present in the following documents:
  • Main text
View BVdb publication page



Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Nature Genetics
Mullighan, Charles G CG; Collins-Underwood, J Racquel JR; Phillips, Letha A A LA; Loudin, Michael G MG; Liu, Wei W; Zhang, Jinghui J; Ma, Jing J; Coustan-Smith, Elaine E; Harvey, Richard C RC; Willman, Cheryl L CL; Mikhail, Fady M FM; Meyer, Julia J; Carroll, Andrew J AJ; Williams, Richard T RT; Cheng, Jinjun J; Heerema, Nyla A NA; Basso, Giuseppe G; Pession, Andrea A; Pui, Ching-Hon CH; Raimondi, Susana C SC; Hunger, Stephen P SP; Downing, James R JR; Carroll, William L WL; Rabin, Karen R KR
Publication Date: 2009-11

Variant appearance in text: JAK2: R683S
PubMed Link: 19838194
Variant Present in the following documents:
  • Main text
View BVdb publication page



A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation.

The Journal Of Biological Chemistry
Zhao, Lequn L; Dong, Hongyun H; Zhang, Cheng Cheng CC; Kinch, Lisa L; Osawa, Mitsujiro M; Iacovino, Michelina M; Grishin, Nikolai V NV; Kyba, Michael M; Huang, Lily Jun-shen LJ
Publication Date: 2009-09-25

Variant appearance in text: JAK2: R683S
PubMed Link: 19638629
Variant Present in the following documents:
  • Main text
View BVdb publication page



JAK mutations in high-risk childhood acute lymphoblastic leukemia.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Mullighan, Charles G CG; Zhang, Jinghui J; Harvey, Richard C RC; Collins-Underwood, J Racquel JR; Schulman, Brenda A BA; Phillips, Letha A LA; Tasian, Sarah K SK; Loh, Mignon L ML; Su, Xiaoping X; Liu, Wei W; Devidas, Meenakshi M; Atlas, Susan R SR; Chen, I-Ming IM; Clifford, Robert J RJ; Gerhard, Daniela S DS; Carroll, William L WL; Reaman, Gregory H GH; Smith, Malcolm M; Downing, James R JR; Hunger, Stephen P SP; Willman, Cheryl L CL
Publication Date: 2009-06-09

Variant appearance in text: JAK2: R683S
PubMed Link: 19470474
Variant Present in the following documents:
  • Main text
View BVdb publication page



Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Blood
Malinge, Sébastien S; Izraeli, Shai S; Crispino, John D JD
Publication Date: 2009-03-19

Variant appearance in text: JAK2: R683S
PubMed Link: 19139078
Variant Present in the following documents:
  • Main text
View BVdb publication page